Loading clinical trials...
Loading clinical trials...
Development and Validation of a Diagnosis Questionnaire of Primary Parkinsonian Pain: the 3 PDQ Primary Parkinsonian Pain Diagnostic Questionnaire
Development and validation of a diagnosis questionnaire of parkinsonian primary pain: the "Primary Parkinsonian Pain Diagnostic Questionnaire" (3PDQ)
The aim of this study is to develop and validate a French self-questionnaire to diagnose parkinsonian primary : the "Primary Parkinsonian Pain Diagnostic Questionnaire" (3PDQ). It will allow clinicians to distinguish this pain from the other pain of the parkinsonian patient (whether or not related to Parkinson's disease). The development and validation of the 3PDQ self-questionnaire will take place in 3 sequential steps: 1. design of the self-questionnaire 2. appearance validity study 3. validation of the self-questionnaire Participants : Appearance validity study: 40 painful parkinsonian patients Validation study: 200 painful parkinsonian patients (10 patients per item) Duration of the study : Duration of the inclusion period: * Appearance validity study : 6 months * Validity study : 20 months Duration of participation for each patient: * Appearance validity study : about 30 min * Validity study : 3 days maximum Total duration of the study: (with results analysis): 3 years
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Neurology service
Clermont-Ferrand, France
Neurology service
Lille, France
Neurology service
Lyon, France
Neurology service
Marseille, France
Neurology Service
Montpellier, France
Neurolgoy service
Nancy, France
Neurology service
Nantes, France
Neurology service
Rouen, France
Neurology service
Strasbourg, France
Neurology service
Toulouse, France
Start Date
April 23, 2019
Primary Completion Date
December 14, 2022
Completion Date
December 14, 2022
Last Updated
February 13, 2023
227
ACTUAL participants
Self-questionnaire 3PDQ
DIAGNOSTIC_TEST
Lead Sponsor
University Hospital, Toulouse
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06113640